Vitamin D Research
back to research menu
Vitamin D and Multiple Sclerosis
- Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol. 2008 Feb;194(1–2):7–17. Review.
- A longitudinal study of serum 25-hydroxyvitamin D and intact PTH levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):152–7.
- Therapeutic potential of vitamin D for multiple sclerosis. Curr Med Chem. 2008;15(5):499–505. Review.
- Vitamin D status modulates the immune response to Epstein Barr virus: Synergistic effect of risk factors in multiple sclerosis. Med Hypotheses. 2008;70(1):66–9.
- Vitamin D insufficiency—possible etiologic factor of autoimmune diseases. Ugeskr Laeger. 2007 Oct 22;169(43):3655–60. Review in Danish.
- 1,25-dihydroxyvitamin D(3) reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. J Neurosci Res. 2007 Aug 15;85(11):2480–90.
- Favourable and unfavourable effects of exposure to sunlight. Ned Tijdschr Geneeskd. 2007 Jan 13;151(2):118–22. Review In Dutch.
- Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis. JAMA. 2006 Dec;296:2832–2838.
- IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J Immunol. 2006 Nov 1;177(9):6030–7.
- Vitamin D physiology. Prog Biophys Mol Biol. 2006 Sep;92(1):4–8. Review.
- Vitamin D and its role in immunology: Multiple sclerosis, and inflammatory bowel disease. Prog Biophys Mol Biol. 2006 Sep;92(1):60–4. Review.
- The role of vitamin D in multiple sclerosis. Ann Pharmacother. 2006 Jun;40(6):1158–61. Review.
- 1,25 dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis. 2006 May 15;83(7):1299–309.
- Vitamin D and autoimmune disease—implications for practice from the multiple sclerosis literature. J Am Diet Assoc. 2006 Mar;106(3):418–24. Review.
- Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev. 2005 Jun;10(2):94–111. Review.
- Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest. 2005 May;35(5):290–304. Review.
- A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis. JNNP 2005;76:1294–1296.
- Multiple sclerosis and vitamin D: an update. Eur J Clin Nutr. 2004 Aug;58(8):1095–109. Review.
- Vitamin D intake and incidence of multiple sclerosis. Neurology. 2004;62:60–65.
- Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ. 2003 Aug 9;327(7410):316.
- Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol. 2003 Jan;134(1–2):128–32.
- Ultraviolet radiation and health: friend and foe. Med J Aust. 2002 Dec 2–16;177(11–12):594–8.
- CD8(+) T cells are not necessary for 1 alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice. Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5557–60.
- Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol. 2000 Aug;48(2):271–2. Letter.
- Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates. Occup Environ Med. 2000 Jun;57(6):418–21.
- Vitamin D and multiple sclerosis. Proc Soc Exp Biol Med. 1997 Oct;216(1):21–7. Review.
- 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7861–4.
- Multiple sclerosis and prostate cancer: what do their similar geographies suggest? Neuroepidemiology. 1992;11(4–6):244–54.
- Is Parkinson's disease acquired? Evidence from a geographic comparison with multiple sclerosis. Neurology. 1987 Mar;37(3):467–71.
back to research menu